Abstracts S150 vanco+Alinia;vanco+Kefir);unsuccessfulvancowithsuccessful2ndFMT 2;1death(hospicecare).30ofthesuccessfullyRxdptshadstooltoxinassay duringf/u:all30negative.Duringlong-termfollow-up,30ptsreceivedantibiotics for other infections and CDI recurred in 8 of these pts (27%) but in no others. 2 had a successful 2nd FMT. When asked about their choice of RxifCDIrecurred,53%wouldhaveFMTastheirpreferred1stRx.7deaths occurredduringf/u:only1possiblyrelatedtoCDI.Twoptshadimprovement in a medical condition existing pre-FMT: arthritis (1), sinus allergies (1). 4 ptsdevelopedanewmedicalconditionofpotentialinterestduringfollow-up; peripheralneuropathyinanon-diabetic;Sjogren's;ITP;rheumatoidarthritis. Conclusion: 1.FMThadasuccessrateof91%ofRCDIinptswhowere,on average, elderly, debilitated and had undergone multiple failed Rx courses, including alternative antibiotics, pulse and tapered Vanco, and probiotics. 2. Despite a mean length of illness of 11 mos, response to FMT was rapid

